发明授权
US07981843B2 Antibody specificity transfer using minimal essential binding determinants
有权
使用最小必需结合决定簇的抗体特异性转移
- 专利标题: Antibody specificity transfer using minimal essential binding determinants
- 专利标题(中): 使用最小必需结合决定簇的抗体特异性转移
-
申请号: US11040159申请日: 2005-01-20
-
公开(公告)号: US07981843B2公开(公告)日: 2011-07-19
- 发明人: Peter Flynn , Kenneth Luehrsen , Robert F. Balint , Jeng-Horng Her , Christopher R. Bebbington , Geoffrey T. Yarranton
- 申请人: Peter Flynn , Kenneth Luehrsen , Robert F. Balint , Jeng-Horng Her , Christopher R. Bebbington , Geoffrey T. Yarranton
- 申请人地址: US CA South San Francisco
- 专利权人: KaloBios Pharmaceuticals, Inc.
- 当前专利权人: KaloBios Pharmaceuticals, Inc.
- 当前专利权人地址: US CA South San Francisco
- 代理机构: Kilpatrick Townsend & Stockton
- 主分类号: C40B30/04
- IPC分类号: C40B30/04 ; C07H21/04
摘要:
The present invention provides methods of making antibodies having the binding specificity of a reference antibody. Antibodies generated by the methods of the inventions have at least one minimal essential binding specificity determinant from a heavy chain or light chain CDR3 from the reference antibody. The method can be used, e.g., in humanization procedures. The invention also provides libraries and antibodies made in accordance with the methods.
公开/授权文献
信息查询